InQ Biosciences is a provider of innovative technologies for research and development in cell and tissue growth. The company's InQ Cell Research System empowers scientists to unlock novel and more powerful approaches to neurological and cell-based discovery. The firm was founded in 2007 with cell culture equipment technology originating from the University of Alabama in Huntsville. Initial InQ instrument deliveries occurred in September 2011, and commercial quantities will be available in early 2012.
What We Do!
InQ Biosciences uses the latest digital engineering and software technologies to create the first generation of fully integrated advanced cell culture laboratory instruments. The InQ system enables cell researchers to develop breakthrough therapies and cures for disease.
Why It Matters!
InQ Biosciences cell research instruments provide unprecedented research capabilities that empower researchers to cure diseases in a highly productive and efficient manner.
Why It's Better!
InQ Biosciences provides the first fully integrated cell research system, which allows for ultimate experimental control and reproducibility. The experiment parameters and data/images can be controlled and monitored over a mobile phone or laptop from anywhere, anytime.
InQ Bio sells its cell culture equipment into a $5 billion market that is growing at about 12% per year. The company is focusing on a wide range of cell research fields. Initially, we are targeting the neurological and stem cell segments, where cell and tissue growth are difficult and delicate tasks. These segments will benefit the most from the high-fidelity cell growth environment provided by the InQ system. Our technology empowers researchers to conduct groundbreaking research by accurately simulating hundreds of neurodegenerative disease states, including stroke, heart attack, Alzheimer's, and ALS.